跳至主要内容
临床试验/CTRI/2021/02/030921
CTRI/2021/02/030921尚未招募4 期

â??An Open label , two arms active controlled and randomized , Clinical Study to Evaluate the Efficacy and Safety of Sugarlite, A Unique Sugar Blended Formulation in Normal to Mild overweight subjects.â??

Zydus Wellness0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • •Subjects of both sexes in the age group of 18 - 45 years
  • •Normal to Pre obese subjects (BMI â?? 23.00kg/M2 to 26 kg/M2)
  • •Subjects willing to give written informed consent.
  • •Those who agree to follow the general guidelines on diet, sugar intake and exercise.
  • •Subjects who have not participated in similar kind of study in last 4 weeks.

排除标准

  • •Subjects with established hypertension, renal, hepatic or cardiac failure
  • •Endocrine disorders like Hypothyroid ( if already on treatment)
  • •Subjects with Dyslipidemia or Inborn errors of Fat metabolism.
  • •Subjects with Postprandial sugars above 150 mg /dl in two tests so can be labelled
  • •Early Diabetic
  • •History of drug hyper sensitivity or allergic condition that might interfere with the study
  • •Use of drugs or dietary supplements that might influence body weight, body fat, or serum lipid levels like Anti diabetic drugs like Metformin and Statins.
  • •Pregnant & lactating women.
  • •Not willing to sign informed consent form.

研究者

相似试验